Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Corcept Therapeutics (CORT) over the last 13 years, with Q3 2025 value amounting to $19.7 million.

  • Corcept Therapeutics' Income towards Parent Company fell 5834.2% to $19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.2 million, marking a year-over-year decrease of 2514.68%. This contributed to the annual value of $141.2 million for FY2024, which is 3304.03% up from last year.
  • As of Q3 2025, Corcept Therapeutics' Income towards Parent Company stood at $19.7 million, which was down 5834.2% from $35.2 million recorded in Q2 2025.
  • Corcept Therapeutics' 5-year Income towards Parent Company high stood at $47.2 million for Q3 2024, and its period low was $15.8 million during Q1 2023.
  • Over the past 5 years, Corcept Therapeutics' median Income towards Parent Company value was $27.8 million (recorded in 2024), while the average stood at $28.2 million.
  • In the last 5 years, Corcept Therapeutics' Income towards Parent Company skyrocketed by 8907.43% in 2023 and then plummeted by 5834.2% in 2025.
  • Over the past 5 years, Corcept Therapeutics' Income towards Parent Company (Quarter) stood at $32.1 million in 2021, then plummeted by 48.2% to $16.6 million in 2022, then soared by 89.07% to $31.4 million in 2023, then dropped by 1.96% to $30.8 million in 2024, then tumbled by 36.09% to $19.7 million in 2025.
  • Its Income towards Parent Company was $19.7 million in Q3 2025, compared to $35.2 million in Q2 2025 and $20.5 million in Q1 2025.